Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viveve Medical Inc (NQ: VIVE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viveve Medical Inc

< Previous 1 2 3 4 Next >
Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout
Via ACCESSWIRE
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
Via ACCESSWIRE
Viveve to Participate in Alliance Global Partners Virtual MedTech Conference
Via ACCESSWIRE
Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Recap: Viveve Medical Q4 Earnings
Viveve Medical (NASDAQ:VIVE) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Via ACCESSWIRE
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today... 
From Viveve Medical, Inc.
Via AccessWire
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
ENGLEWOOD, CO / ACCESSWIRE / July 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today... 
From Viveve Medical, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 94 companies set new 52-week lows. 
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 215 companies set new 52-week lows. 
Via Benzinga
Viveve to Participate in H.C. Wainwright Global Investment Conference
ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will... 
From Viveve Medical, Inc.
Via AccessWire
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in women ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 /... 
From Viveve Medical, Inc.
Via AccessWire
Recap: Viveve Medical Q1 Earnings
Viveve Medical (NASDAQ:VIVE) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Viveve Medical reported in-line... 
Via Benzinga
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
Total revenue of $1.6 million in Q1 including sale of 2,750 consumable treatment tips PURSUIT trial top-line results anticipated at end of 2022 Conference call to be hosted by Company at 5:00 PM ET... 
From Viveve Medical, Inc.
Via AccessWire
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Viveve Medical, Inc.
Via AccessWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million. 
Via Benzinga
Looking Into Viveve Medical's Return On Invested Capital
Benzinga Pro data, Viveve Medical (NASDAQ:VIVE) reported Q4 sales of $1.71 million. Earnings fell to a loss of $6.33 million, resulting in a 8.02% decrease from last quarter.... 
Via Benzinga
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growth Enrollment completed in U.S. pivotal PURSUIT trial for stress urinary incontinence and 12-month post... 
From Viveve Medical, Inc.
Via AccessWire
Earnings Scheduled For March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
Earnings Preview For Viveve Medical
Viveve Medical (NASDAQ:VIVE) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Viveve to Report Full Year 2021 Financial Results and Provide Corporate Update on March 17, 2022
ENGLEWOOD, CO / ACCESSWIRE / March 3, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its full year 2021... 
From Viveve Medical, Inc.
Via AccessWire
Healthcare Technology Report Names Viveve Regulatory Executive Among Top 25 Women Leaders in Medical Devices
Viveve SVP Suzon Lommel named to list for second consecutive year for efforts to advance innovative technologies to treat stress urinary incontinence in women ENGLEWOOD, CO / ACCESSWIRE / January 13,... 
From Viveve Medical, Inc.
Via AccessWire
Viveve to Participate in H.C. Wainwright BIOCONNECT Conference
ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer,... 
From Viveve Medical, Inc.
Via AccessWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXT... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.